Polaris Market Research07.16.21
The global medical oxygen concentrators & oxygen cylinders market size is expected to reach USD 4.62 billion by 2028 according to a new study by Polaris Market Research.
Medical concentrators and cylinders are medical oxygen systems that are used to treat respiratory ailments and are commonly preferred by older patients who have limited mobility and rely on a consistent market supply. A few common chronic health conditions, such as chronic obstructive pulmonary disease (COPD), emphysema, and chronic bronchitis, necessitate oxygen therapy or supplementary oxygen.
The emergence of the COVID-19 pandemic has given significantly boosted market growth for medical concentrators and cylinders. By April 2021, nearly 150 million COVID-19 cases had been diagnosed around the world, with no indication of the pandemic slowing down in many areas. India is facing a huge supply crisis as a result of the flaming COVID-19 pandemic, and in April 2021, the central government has agreed to import concentrators and cylinders from the United States and has placed an order for ten thousand concentrators.
The need for these concentrators and cylinders has also increased in the market in recent years due to the increased prevalence of chronic obstructive pulmonary disease (COPD), and other respiratory illnesses. According to American Lung Association, in 2018, over 16.4 million (6.6 percent adults), US adults were diagnosed with any type of COPD, around 9 million with chronic bronchitis, and 2 million with emphysema.
The increasing market demand for medical concentrators and cylinders has resulted in the introduction and approval of new products in the market. For instance, In April 2021, Belluscura received U.S. Food and Drug Administration approval for its X-PLO₂R portable concentrators. It is a lightweight system that is specifically designed to treat COPD and other respiratory disorders.
Exalta, based in New Delhi, India, has introduced a portable mini ventilator with an integrated concentrator, in April 2021, to help market consumers deal with decreasing O2 levels due to coronavirus outbreaks. The mini ventilators are water based pure O2 concentrators that delivers one to eight liters of oxygen per minute.
Koninklijke Philips N.V. (Philips Respironics), CAIRE INC., Drive DeVilbiss Healthcare Inc., Invacare Corporation, Inogen Inc., Nidek Medical Products Inc., O2 Concepts LLC, OxyGo LLC, Precision Medical Inc., ResMed, Linde plc, GCE Group (GCE Healthcare) and Cramer Decker Medical Inc., are some of the key market players operating in the global market for medical O2 concentrators and O2 cylinders.
Medical concentrators and cylinders are medical oxygen systems that are used to treat respiratory ailments and are commonly preferred by older patients who have limited mobility and rely on a consistent market supply. A few common chronic health conditions, such as chronic obstructive pulmonary disease (COPD), emphysema, and chronic bronchitis, necessitate oxygen therapy or supplementary oxygen.
The emergence of the COVID-19 pandemic has given significantly boosted market growth for medical concentrators and cylinders. By April 2021, nearly 150 million COVID-19 cases had been diagnosed around the world, with no indication of the pandemic slowing down in many areas. India is facing a huge supply crisis as a result of the flaming COVID-19 pandemic, and in April 2021, the central government has agreed to import concentrators and cylinders from the United States and has placed an order for ten thousand concentrators.
The need for these concentrators and cylinders has also increased in the market in recent years due to the increased prevalence of chronic obstructive pulmonary disease (COPD), and other respiratory illnesses. According to American Lung Association, in 2018, over 16.4 million (6.6 percent adults), US adults were diagnosed with any type of COPD, around 9 million with chronic bronchitis, and 2 million with emphysema.
The increasing market demand for medical concentrators and cylinders has resulted in the introduction and approval of new products in the market. For instance, In April 2021, Belluscura received U.S. Food and Drug Administration approval for its X-PLO₂R portable concentrators. It is a lightweight system that is specifically designed to treat COPD and other respiratory disorders.
Exalta, based in New Delhi, India, has introduced a portable mini ventilator with an integrated concentrator, in April 2021, to help market consumers deal with decreasing O2 levels due to coronavirus outbreaks. The mini ventilators are water based pure O2 concentrators that delivers one to eight liters of oxygen per minute.
Koninklijke Philips N.V. (Philips Respironics), CAIRE INC., Drive DeVilbiss Healthcare Inc., Invacare Corporation, Inogen Inc., Nidek Medical Products Inc., O2 Concepts LLC, OxyGo LLC, Precision Medical Inc., ResMed, Linde plc, GCE Group (GCE Healthcare) and Cramer Decker Medical Inc., are some of the key market players operating in the global market for medical O2 concentrators and O2 cylinders.